Keyphrases
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
17%
Acute Coronary Syndrome
36%
Advanced Kidney Disease
11%
Antithrombotic Therapy
18%
Asian Patients
11%
Atrial Fibrillation
26%
Beck Depression inventory-II (BDI-II)
16%
Bladder Cancer
27%
Bleeding
15%
Bleeding Risk
18%
Cardiac Arrest
12%
Children with Down Syndrome
15%
Chronic Kidney Disease
35%
Clinical Outcomes
26%
Clinical Practice
11%
Cognitive Behavioral Therapy
11%
Common Marmoset
27%
Comorbidity
24%
Confidence Interval
23%
Cost-effectiveness
13%
COVID-19
34%
COVID-19 Pandemic
21%
Depressive Symptoms
16%
Diabetes
33%
Diabetic
11%
Dialysis
76%
Dialysis Patients
18%
Disease Activity
14%
Disease Activity Score 28 (DAS28)
13%
Dopamine
11%
Dual Antiplatelet Therapy
18%
Dyskinesia
19%
Early Rheumatoid Arthritis
30%
Elderly Patients
14%
End-stage Kidney Disease
15%
End-stage Renal Disease
15%
Endogenous Fibrinolysis
31%
Epilepsy
17%
Ethnic Minorities
11%
Fibrinolysis
19%
Global Thrombosis Test
15%
Hazard Ratio
11%
Health Assessment Questionnaire
11%
Hemodiafiltration
18%
Hemodialysis
99%
Hemodialysis Patients
76%
High Dose
11%
High Risk
14%
High-flux Hemodialysis
15%
Inception Cohort
23%
Incremental Hemodialysis
12%
Inducible Nitric Oxide Synthase
10%
Inflammation
26%
Kidney
11%
Kidney Care
19%
Kidney Patients
12%
Levodopa-induced Dyskinesia
12%
Maintenance Hemodialysis Patients
22%
Meta-analysis
49%
Muscle-invasive Bladder Cancer
15%
Myocardial Infarction
11%
Neoadjuvant Chemotherapy
15%
Novel Psychoactive Substances
16%
Odds Ratio
11%
Older Patients
11%
P2Y12 Inhibitors
12%
Parkinson's Disease
16%
Patient Experience
24%
Patient-reported Experience Measures
16%
People with Intellectual Disabilities
11%
Percutaneous Coronary Intervention
23%
Peritoneal Dialysis
14%
Peritoneal Dialysis Patients
11%
Platelet Reactivity
14%
Prostate Cancer
11%
Prothrombotic Status
11%
Quality of Life
27%
Radical Cystectomy
20%
Randomized Controlled Trial
39%
Renal Replacement Therapy
17%
Residual Renal Function
32%
Resting Energy Expenditure
12%
Rheumatoid Arthritis
50%
Robot-assisted Laparoscopic Radical Prostatectomy
12%
Robot-assisted Radical Cystectomy
15%
Scoping Review
15%
South Asian
20%
ST-elevation Myocardial Infarction (STEMI)
26%
Streptozotocin
24%
Systematic Meta-analysis
33%
Thrombosis
24%
Thrombotic
12%
Thrombus
13%
Thrombus Formation
12%
Ticagrelor
12%
Total Energy Expenditure
13%
UK Renal Registry
20%
United Kingdom
16%
Young People
15%
β2-microglobulin (β2-MG)
12%
Medicine and Dentistry
1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine
9%
Acute Coronary Syndrome
20%
Acute Heart Infarction
9%
Acute Kidney Injury
9%
Adverse Event
8%
Anticoagulation
13%
Antiplatelet
17%
Antithrombotic
27%
Antithrombotic Therapy
10%
Apoplexy
11%
Arm
12%
Artery Thrombosis
8%
Atrial Fibrillation
17%
Awareness
11%
Beck Depression Inventory
7%
Biological Marker
19%
Biopsy Technique
11%
Bladder
13%
Bladder Cancer
26%
Bleeding
20%
Blood Clotting
9%
Cardiovascular Disease
17%
Cardiovascular System
19%
Chronic Kidney Disease
41%
Clinician
11%
Cohort Analysis
8%
Cohort Study
9%
Comorbidity
20%
Computer Assisted Tomography
10%
Coronary Artery Disease
14%
Cost-Effectiveness Analysis
10%
COVID-19
42%
Creatinine
8%
Cystectomy
32%
DAS28
10%
Diabetes
25%
Diabetes Mellitus
17%
Diagnosis
8%
Disease
34%
Disease Activity
12%
Down Syndrome
9%
Drug Therapy
22%
Elderly Patient
11%
End Stage Renal Disease
38%
Endotoxin
7%
Fibrinolysis
29%
Function Test
8%
Hazard Ratio
8%
Health Care Cost
9%
Heart Arrest
11%
Hemodiafiltration
9%
Hemodialysis
100%
In Vitro
12%
Infection
14%
Inflammatory Arthritis
47%
Kidney Function
33%
Kidney Transplantation
12%
Learning Disorder
8%
Malignant Neoplasm
11%
Maturity Onset Diabetes of the Young
9%
Mental Health
15%
Meta-Analysis
34%
Muscle Invasive Bladder Cancer
15%
Myocardial Infarction
15%
Neoadjuvant Chemotherapy
14%
Neoplasm
18%
Nephropathy
21%
Observational Study
8%
Obsessive Compulsive Disorder
8%
Odds Ratio
8%
Orthopedic Surgery
8%
Patient Experience
24%
Patient Referral
12%
Patient-Reported Outcome
8%
Percutaneous Coronary Intervention
17%
Peritoneal Dialysis
19%
Platelet
12%
Platelet Reactivity
11%
Prevalence
32%
Primary Percutaneous Coronary Intervention
9%
Prostate Cancer
25%
Prostatectomy
16%
Public Health
9%
Quality of Life
32%
Randomized Controlled Trial
43%
Renal Failure
10%
Renal Replacement Therapy
17%
Resuscitation
9%
Rheumatoid Arthritis
47%
Robot-Assisted Prostatectomy
14%
ST Segment Elevation Myocardial Infarction
16%
Streptozocin
9%
Surgery
8%
Systematic Review
40%
Thrombin
7%
Thrombocyte Function
12%
Thrombosis
36%
Thrombus
12%
Transplantation
19%
Urinary System
11%